Dernières nouvelles pour Polestar Automotive (NASDAQ:PSNY) Stock

Polestar Automotive

Polestar Automotive Holding UK PLC operates as an electric vehicle manufacturer. It engages in designing products that are engineered to excite consumers and drive change. Polestar defines market-leading standards in design, technology, and sustainability. Polestar was established as a premium electric car brand by Volvo Cars and Geely Holdings. Polestar has produced two electric performance cars namely Polestar 1 and Polestar 2. Geographically, it derives a majority of revenue from USA.

Polestar Automotive Holding UK Limited - Class A ADS

Polestar Automotive Holding UK PLC

Polestar Automotive Holding UK Limited - Class C-1 ADS (ADW)

Macro Economic Events

News

Economics

China's President Xi Meets British Prime Minister Starmer In Rio, Calls For Strengthening Strategic Partnership, Cooperation In Trade, Clean Energy, And AI Governance; Highlights Mutual Respect And Deeper Political Trust To Tackle Global Challenges

EON Resources (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/EONR#AMEX">EONR</a>) reported quarterly losses of $(0.67) per share which missed the analyst consensus estimate of $(0.35) by 91.43 percent. This is a 59.88 percent increase over losses of $(1.67) per share from the same period last year. The company reported quarterly sales of $7.36 million which beat the analyst consensus estimate of $5.20 million by 41.62 percent. This is a 53.12 percent decrease over sales of $15.71 million the same period last year.

Earnings

EONR

EON Resources Q3 EPS $(0.67) Misses $(0.35) Estimate, Sales $7.36M Beat $5.20M Estimate

With the conversion unit already shipped and located on site, Eco Wave Power plans to complete installation by the end of Q1 2025.

Contracts

WAVE

Eco Wave Power Receives Final Permit From U.S. Army Corps Of Engineers For U.S. First Wave Energy Project

Walmart Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WMT#NYSE">WMT</a>) will release earnings results for the third quarter, before the <a href="https://www.benzinga.com/quote/WMT/earnings">opening bell on Nov. 19</a>.
Analysts expect the Bentonville, Arkansas-based company to report quarterly earnings at 53 cents per share. That&#8217;s up from 51 cents per share in the year-ago period. Walmart projects to report quarterly revenue of $166.57 billion, compared to $159.44 billion a year earlier, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
On Friday, Jefferies analyst Corey Tarlowe maintained Walmart with a Buy rating and raised the price target from $90 to $100.
With the recent buzz around Walmart, some investors may be eyeing potential gains from the company's dividends, too. Walmart currently offers an annual dividend yield of 0.99%, which is a quarterly dividend amount of 20.75 cents per share (83 cents a year).
So, how can investors exploit its dividend yield to pocket a regular $500 monthly?
To earn $500 per month or $6,000 annually from dividends alone, you would need an investment of approximately $609,043 or around 7,229 shares. For a more modest $100 per month or $1,200 per year, you would need $121,826 or around 1,446 shares.
To calculate: Divide the desired annual income ($6,000 or $1,200) by the dividend (83 cents). So, $6,000 / $0.83 = 7,229 ($500 per month), and $1,200 / $0.83 = 1,446 shares ($100 per month).
Note that dividend yield can change on a rolling basis, as the dividend payment and the stock price both fluctuate over time.
How that works: The dividend yield is computed by dividing the annual dividend payment by the stock&#8217;s current price.
For example, if a stock pays an annual dividend of $2 and is currently priced at $50, the dividend yield would be 4% ($2/$50). However, if the stock price increases to $60, the dividend yield drops to 3.33% ($2/$60). Conversely, if the stock price falls to $40, the dividend yield rises to 5% ($2/$40).
Similarly, changes in the dividend payment can impact the yield. If a company increases its dividend, the yield will also increase, provided the stock price stays the same. Conversely, if the dividend payment decreases, so will the yield.
WMT Price Action: Shares of Walmart fell 0.3% to close at $84.25 on Friday.
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="How to Find Dividend Stocks: Scan, Analyze, and Capture with Benzinga Pro" width="500" height="281" src="https://www.youtube.com/embed/pVF0O2lsEH4?start=1&#038;feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/markets/24/11/42024062/how-to-earn-500-a-month-from-apple-stock">How To Earn $500 A Month From Apple Stock</a></li>
</ul>
Image via Shutterstock

Long Ideas

Markets

Trading Ideas

How To Earn $500 A Month From Walmart Stock Ahead Of Q3 Earnings

Corteva Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CTVA#NYSE">CTVA</a>) announced today a collaboration with bp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BP#NYSE">BP</a>, LSE: BP.L))) on the companies' shared intent to form a crop-based biofuel feedstock joint venture (JV).
The JV envisaged by Corteva and bp would produce and deliver crop-based biofuel feedstocks to help meet the anticipated growth in demand for 'sustainable aviation fuel' (SAF).
A number of countries around the world have, or are in the process of implementing, mandates or tax incentives to promote the decarbonization of the aviation sector. In the EU a SAF mandate begins in 2025 that will require fuel uplift at EU airports to contain at least 20% SAF by 2035 and 70% by 2050.
To help meet this demand, Corteva and bp have executed a non-binding memorandum of understanding, with the intent of forming a JV that would aim to progressively scale up volume, reaching delivery&nbsp;of one million metric tons per year of biofuel feedstocks for SAF production by the mid-2030s.
Corteva plans to contract with farmers in North and South America, and Europe, to grow proprietary Corteva mustard seed, sunflower and canola feedstocks well-suited for SAF production. These crops are integral to large scale agriculture around the world. The JV would aim to introduce new cropping systems to produce oil that meets EU RED III criteria, and qualifies for US Low Carbon Intensity policy incentives, while creating a new revenue stream for farmers.

Biotech

General

CTVA

Corteva Announces A Collaboration With bp On The Companies' Shared Intent To Form A Crop-Based Biofuel Feedstock Joint Venture; The JV Envisaged By Corteva And bp Would Produce And Deliver Crop-Based Biofuel Feedstocks To Help Meet The Anticipated Growth In Demand For 'Sustainable Aviation Fuel'

Morgan Stanley analyst Tejas Savant maintains Myriad Genetics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MYGN#NASDAQ">MYGN</a>) with a Equal-Weight and lowers the price target from $32 to $21.

Price Target

Analyst Ratings

MYGN

Morgan Stanley Maintains Equal-Weight on Myriad Genetics, Lowers Price Target to $21

WIIM

XCUR

Exicure shares are trading higher after the company reported a year-over-year increase in Q3 PES results. Additionally, the company announced it entered into a purchase agreement for $1.3 million and $8.7 million in equity financing.

Preclinical data accepted for online publication at ASH Annual Meeting reveal significant activity of Annamycin in Venetoclax resistant AML model
New preliminary clinical results show Annamycin plus Ara-C achieved 60% CR/CRi in subjects who were relapsed from or refractory to Venetoclax regimens; more than 4 times greater than published historical rates
Annamycin demonstrates an even greater potential than previously reported to address a significant AML patient population for which treatment options are extremely limited
New data from MB-106 trial show median overall survival of 11.6 months in subjects receiving AnnAraC as 2nd line therapy
HOUSTON, Nov. 18, 2024 /PRNewswire/ -- Moleculin Biotech, Inc., (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBRX#NASDAQ">MBRX</a>) ("Moleculin" or the "Company"), a late-stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat tumors and viruses, today announced new findings supporting the ability of Annamycin to overcome resistance to Venetoclax in acute myeloid leukemia ("AML").&nbsp; This includes data from preclinical in vitro studies recently accepted for online publication at the upcoming American Society of Hematology ("ASH") Annual Meeting, and correlates with efficacy demonstrated by recent preliminary clinical data in subjects who were relapsed from or refractory to first line Venetoclax regimens and were then treated with Annamycin in combination with Ara-C ("AnnAraC").

MBRX

Moleculin Biotech  Announces New Findings Supporting The Ability Of Annamycin To Overcome Resistance To Venetoclax In Acute Myeloid Leukemia; Preclinical Data Accepted For Online Publication At ASH Annual Meeting Reveal Significant Activity Of Annamycin In Venetoclax Resistant AML Model

Morgan Stanley analyst Hamza Fodderwala maintains CrowdStrike Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWD#NASDAQ">CRWD</a>) with a Overweight and raises the price target from $325 to $355.

CRWD

Morgan Stanley Maintains Overweight on CrowdStrike Holdings, Raises Price Target to $355

THAR

Tharimmune shares are trading higher after the company announced it will present at the 75th AASLD liver meeting.

ANIX

Anixa Biosciences Initiates Dosing In The Third Cohort Of Its Ovarian Cancer CAR-T Clinical Trial

Coinbase CEO Brian Armstrong has proposed <a href="https://www.benzinga.com/money/what-is-income-tax">eliminating individual income taxes </a>in the U.S., suggesting a radical shift in the tax burden to businesses and alternative revenue sources like sales taxes.
What Happened: Armstrong's <a href="https://x.com/brian_armstrong/status/1858208662864429185">call</a>, shared in a series of tweets on Sunday, aligns with his broader vision for reducing government size and enhancing economic freedom.
&#8220;It's kind of crazy that we ask every adult in the U.S. to figure out how to pay their taxes,&#8221; Armstrong tweeted, pointing to the complexity of the current tax code, which spans an estimated 150,000 pages. 
He argued that offloading the tax reporting burden from millions of individual Americans to approximately 10,000 of the largest companies would simplify the system significantly.
Armstrong added, "Try to generate equivalent revenue via a sales tax, or on business income, etc."
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/events/digital-assets/ "><img loading="lazy" decoding="async" width="300" height="250" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/03/29155259/905735A6-57D3-4874-9AA1-75D037842DB3-2.gif" alt="Benzinga Future of Digital Assets conference" class="wp-image-270548" /></a></figure>
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42010782/goldman-sachs-expands-bitcoin-etf-holdings-to-710-million">Goldman Sachs Expands Bitcoin ETF Holdings To $710 Million</a>
He also <a href="https://x.com/brian_armstrong/status/1858023954776207730">highlighted</a> United States Department of Government Efficiency&#8217;s unique potential to drive economic freedom in the U.S., describing it as a &#8220;once-in-a-lifetime opportunity.&#8221;
On Nov. 13, Trump officially named Musk and Ramaswamy as leaders of a newly established agency focused on optimizing federal operations through waste reduction, regulatory cuts, and agency restructuring.
He cited the need for systemic reforms, including a potential constitutional amendment capping government expenditure, to curtail what he sees as adverse incentives that expand government size over time. 
Armstrong proposed, "Every citizen then has skin in the game," suggesting a U.S. sovereign wealth fund that would provide citizens with shares and dividends from budget surpluses.
What&#8217;s Next: The debate is particularly timely as the industry prepares for events like Benzinga's <a href="https://www.benzinga.com/events/digital-assets/agenda/">Future of Digital Assets</a> conference on Nov. 19, where such disruptive ideas and technologies are set to take center stage.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42007247/bitcoin-dogecoin-success-driven-by-narrative-and-momentum-report-argues">Bitcoin, Dogecoin Success Driven By &#8216;Narrative And Momentum,&#8217; Report Argues</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Coinbase CEO Brian Armstrong Says DOGE Department Is A 'Once-In-A-Lifetime-Opprtunity,' Advocates Abolishing Individual Income Tax

SINT

SiNtx Technologies shares are trading higher after the company announced plans to buy back up to $500K worth of common stock in the upcoming quarters which can reduce the total shares outstanding by approximately 20%.

Icovamenib Achieves a Mean Reduction in HbA1c Greater than 1% at Week 26 Following 4 Weeks of Dosing in Type 2 Diabetes Patients Characterized by Insulin Deficiency
<ul>
<li>32 patients from the 100mg and 200mg cohorts, doses selected for the expansion phase, were characterized based on baseline biomarkers and analyzed for efficacy. Patients identified as insulin deficient (approx. 50% of the broader patient population) and insulin resistant were compared to examine the mean reduction in HbA1c at Week 26, following 4 weeks of dosing.</li>
<li>83%&nbsp;of patients with insulin deficiency responded to icovamenib, and showed a greater mean HbA1c reduction at Week 26 compared to baseline, than those that were found to be more insulin resistant (-1.23% vs -0.48%, placebo-adjusted, 22 weeks after last dose of icovamenib).</li>
<li>These two patient groups are pre-specified in the upcoming read out of the Phase IIb expansion portion of COVALENT-111 in December, reporting over 200 persons with type 2 diabetes (T2D) with 8 and 12 weeks of icovamenib treatment.</li>
</ul>

BMEA

Biomea Fusion Announces Late-Breaker Oral Presentation Showing New Analysis From The Escalation Portion Of COVALENT-111 Presented At The 1st Annual Asian Conference On Innovative Therapies For Diabetes Management; Icovamenib Achieves A Mean Reduction In HbA1c Greater Than 1% At Week 26 Following 4 Weeks Of Dosing In Type 2 Diabetes Patients Characterized By Insulin Deficiency

Morgan Stanley analyst Stephen Byrd maintains Bloom Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BE#NYSE">BE</a>) with a Overweight and raises the price target from $20 to $28.

Morgan Stanley Maintains Overweight on Bloom Energy, Raises Price Target to $28

BTBT

Bit Digital shares are trading lower after the company reported worse-than-expected Q3 financial results.

MBX Biosciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBX#NASDAQ">MBX</a>), a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders, today announced the completion of the last subject's last visit in its Phase 1 single and multiple ascending dose trial of MBX 1416, the Company's long-acting glucagon-like peptide 1 (GLP-1) receptor antagonist in development for the treatment of post-bariatric hypoglycemia (PBH).

MBX Biosciences Announces The Completion Of The Last Subject's Last Visit In Its Phase 1 Single And Multiple Ascending Dose Trial Of MBX 1416, The Company's Long-Acting Glucagon-Like Peptide 1 Receptor Antagonist In Development For The Treatment Of Post-Bariatric Hypoglycemia

Amplify YieldShares Oil Hedged MLP Income ETF

AMLX

Amylyx Pharmaceuticals shares are trading higher after Baird upgraded the stock from Neutral to Outperform and raised its price target from $3 to $11.

ENPH

Enphase Energy Starts U.S. Shipments Of IQ Battery 5Ps, Enabling Projects To Qualify For Domestic Content Bonus Credit Under The Inflation Reduction Act

Morgan Stanley analyst Erik Woodring initiates coverage on Ingram Micro Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/INGM#NYSE">INGM</a>) with a Equal-Weight rating and announces Price Target of $24.

Initiation

INGM

Morgan Stanley Initiates Coverage On Ingram Micro Holding with Equal-Weight Rating, Announces Price Target of $24

Auto stocks and the election: Maybe investors should buckle up

Electric vehicle sales are forecast to reach 9% in the U.S. in October

Polestar (PSNY) has delivered its first U.S.-built Polestar 3 SUVs to customers in the North American market. Deliveries of Polestar 3 began around...

Polestar delivers first U.S.-built Polestar 3 SUVs to North American customers

EV Company News For The Month Of October 2024

Latest data shows the largest indicative borrow rate increases among liquid option names include: LASER PHOTONICS CORPORATION (LASE) 318.19% +52.40...

Largest borrow rate increases among liquid names

The great auto sector unwind: EV stocks fall while ICE suppliers and Ford gain

Latest data shows the largest indicative borrow rate increases among liquid option names include: LASER PHOTONICS CORPORATION (LASE) 232.53% +20.43...

Latest data shows the largest indicative borrow rate increases among liquid option names include: Eldorado Gold (EGO) 4.16% +3.52, GlycoMimetics (G...

Rivian Still Fails To Impress

The EV market that 'sucks'

AAOI

ALSN

ANRO

APTV

AYRO

BAMXF

BATT

BCCMY

BLBD

BLNK

BMCLF

BMWYY

BYDDF

BYDDY

BYMOF

CARZ

CHPT

CVGW

CVNA

DNFGF

DNFGY

DRIV

EOSE

EVGO

EVTV

FFIE

FUJHF

FUJHY

GELYF

GELYY

GLYC

GOEV

GOEVW

GWLLF

GWLLY

HNDAF

HSAI

HYLN

HYMTF

IDEX

INVZ

KNDI

LAAOF

LASE

LAZR

LCID

LTBR

MAHMF

MBGAF

MBGYY

MBLY

MMTOF

MULN

MZDAF

MZDAY

NIOIF

NSANF

NSANY

PHIN

PLOW

POAHF

POAHY

PSNY

PSNYW

RACE

RDDT

RIVN

RNLSY

RNSDF

SERV

STLA

SZKMF

SZKMY

TOYOF

TSLA

VFSWW

VLKAF

VLKPF

VWAGY

VWAPY

WKHS

XIACF

XIACY

XPEV

XPNGF

Press Releases

Polestar Appoints Philipp Römers Head of Design

Polestar Announces Leadership Change: Michael Lohscheller Appointed CEO

Polestar Publishes Q2 2024 Results: 82% Growth in Global Deliveries

Polestar appoints Jean-Francois Mady as CFO

Polestar Announces Date of AGM and Board Changes

Polestar Fully Compliant With Nasdaq Listing Rules

Infosys and Polestar Enter Strategic Collaboration by opening Technology Hub in Bengaluru, India

Polestar Announces Global Volumes for the Third Quarter; to Provide Business and Strategy Update on 16 January 2025

Polestar Now Offers Its Customers Access to One of the World's Largest Charging Networks

Polestar Delivers First Polestar 3 Manufactured in U.S. to North American Customers

INFY

Thunder Power Holdings, Inc. - Common Stock

Thunder Power Holdings

Cenntro

ECD Automotive Design, Inc. - Common Stock

ECD Automotive Design

Envirotech Vehicles

Ford Motor

Faraday Future Intelligent Electric Inc. - Class A Common Stock

Faraday Future

Fly-E Group

General Motors

Canoo

Honda Motor Co

Lucid Gr

Li Auto Inc. - American Depositary Shares

Li Auto

Lotus Technology Inc. - American Depositary Shares

Lotus Technology

NIO Inc. American depositary shares, each representing one Class A ordinary share

NWTN

Rivian Automotive, Inc. - Class A Common Stock

Rivian Automotive

Comments

Polestar Automotive

Actualités

Dernières nouvelles pour Polestar Automotive (NASDAQ:PSNY) Stock

Les gens regardent aussi

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL